Warrenâs Argument That Millions Canât Afford Their Rx Drugs Holds Up
âMedication insecurityâ is a thing.
Drug Costs
281 - 300 of 688 Results
-
-
KHNâs âWhat The Health?â: ACA Still Under A Cloud After Court Ruling
A federal appeals court in New Orleans has agreed with a lower court that a key piece of the Affordable Care Act is unconstitutional. But it is sending the case back to the lower-court judge to decide how much of the rest of the law can stand. Also, Congress is leaving town after finishing work on a major spending bill that includes many changes to health policy. Margot Sanger-Katz of The New York Times, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHNâs Julie Rovner to discuss this and more.
-
Border Fight: Trumpâs Plan To Import Cheaper Drugs From Canada Faces Hurdles
The administrationâs proposed rule to allow states to bring in prescription medications isnât expected to provide immediate relief.
-
Listen: The Cost Of PrEP, The HIV Prevention Pill
KHN correspondent Shefali Luthra was among the guests on the podcast "Today, Explained" to talk about PrEP.
-
Analysis: In Medical Billing, Fraudulent Charges Weirdly Pass As Legal
After my husband had a bike accident, we were subjected to medical bills that no one would accept if they had been delivered by a contractor, or a lawyer or an auto mechanic. Such charges are sanctioned by insurers, which generally pay because they have no way to know whether you received a particular item or service â and itâs not worth their time to investigate the millions of medical interactions they write checks for each day.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Watch: The House Approved H.R. 3, The Pelosi Drug Bill. What Does That Mean?
KHN's Emmarie Huetteman appeared on PBS NewsHour to discuss efforts on Capitol Hill to curb the cost of prescription drugs.
-
KHNâs âWhat The Health?â: Legislate-A-Palooza
The House passed legislation that would give federal workers 12 weeks of paid parental leave. The measure appears headed for passage in the Senate, and President Donald Trump has promised to sign the measure into law. Meanwhile, House and Senate lawmakers have a tentative deal on surprise medical bills, but donât count on a compromise just yet. Joanne Kenen of Politico, Kimberly Leonard of the Washington Examiner and Emmarie Huetteman of Kaiser Health News join guest host Mary Agnes Carey of KHN to discuss this and more. And for âextra credit,â the panelists offer their favorite health stories of the week they think you should read, too.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you donât have to.
-
KHNâs âWhat The Health?â: We Spend HOW MUCH On Health Care?
The annual accounting of national health spending is out. And the 2018 health bill for the U.S. was $3.6 trillion, consuming nearly a fifth of the nationâs economy. Meanwhile, Congress is nearing the end of the year without having finished either its annual spending bills or several other high-priority health items. Kimberly Leonard of the Washington Examiner, Joanne Kenen of Politico and Mary Agnes Carey of Kaiser Health News join KHNâs Julie Rovner to discuss this and more. Also, Rovner interviews KHNâs Markian Hawryluk about the latest KHN-NPR âBill of the Month.â
-
Pharmaâs Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
The pharmaceutical industryâs argument that capping drug prices would compromise drug innovation stands âon very shaky ground.â
-
HHS Hands Out Free HIV Prevention Drugs. Do You Qualify?
Called âReady, Set, PrEP,â the federal program will provide medication that can reduce the chances of getting AIDS to at-risk patients who donât have insurance.
-
KHNâs âWhat The Health?â: Howâs That Open Enrollment Going?
Open enrollment for the Affordable Care Actâs marketplace plans is halfway over and, so far, the number of people signing up is down, but not dramatically. Meanwhile, Congress and President Donald Trump canât seem to agree on what to do about teen vaping, drug prices or âsurpriseâ medical bills. And Democrats lurch to the left on abortion. Paige Winfield Cunningham of The Washington Post, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHNâs Julie Rovner to discuss this and more health news.
-
White House Unveils Finalized Health Care Price Transparency Rule
The final directive drew swift responses from the hospital and insurance industries. The Trump administration also released a proposed rule that would require health insurers to spell out for all services beforehand just how much patients may owe for their out-of-pocket costs.
-
KHNâs âWhat The Healthâ: Spending Bill Slowdown
Itâs November, do you know where your HHS spending bill is? Still stuck in Congress. Meanwhile, lawmakers move ahead on restricting tobacco products for youth while the administrationâs proposal is MIA. Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHNâs Julie Rovner to discuss this and more health news from the week. Also, Rovner interviews Dan Weissmann, host of the podcast âAn Arm and a Leg.â
-
Voters Say Congress Needs To Curb Drug Prices, But Are Lawmakers Listening?
Nearly 8 in 10 Americans say the cost of prescription drugs is unreasonable, but the odds look grim for Congress to pass significant pricing legislation this year.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you donât have to.
-
Listen: HHS Files Challenge Over Rights To Gilead’s HIV-Prevention Drug
KHN's Shefali Luthra discusses the recent Trump administration lawsuit regarding the HIV-prevention drug Truvada.
-
Analysis: Elizabeth Warren Throws Down The Gauntlet
She has led the way, but all the candidates need to come clean about their health care proposals.
-
FDA Keeps Brand-Name Drugs On A Fast Path To Market â Despite Manufacturing Concerns
The agency approved Gileadâs âgame changerâ hepatitis C cure, bypassing concerns raised by its own federal inspectors.